BiotechTube

ONO-8539

Phase 1Completed
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

GERD

Conditions

GERD

Trial Timeline

Dec 1, 2012 → —

NCT ID
NCT01707901

About ONO-8539

ONO-8539 is a phase 1 stage product being developed by Ono Pharmaceutical for GERD. The current trial status is completed. This product is registered under clinical trial identifier NCT01707901. Target conditions include GERD.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (2)

NCT IDPhaseStatus
NCT01705275Phase 1Completed
NCT01707901Phase 1Completed

Competing Products

20 competing products in GERD

See all competitors
ProductCompanyStageHype Score
Rabeprazole ER + RanitidineEisaiPhase 3
77
Rabeprazole sodiumEisaiPhase 1
33
Rabeprazole sodium + EsomeprazoleEisaiPhase 3
77
rabeprazole sodium + PlaceboEisaiPhase 3
77
Rabeprazole ER + RanitidineEisaiPhase 3
77
Rabeprazole sodium 5 mg + Rabeprazole sodium 10 mgEisaiPhase 1
33
rabeprazole + rabeprazoleEisaiPhase 3
77
Rabeprazole sodium + EsomeprazoleEisaiPhase 3
77
Rabeprazole sodium + EsomeprazoleEisaiPhase 3
77
esomeprazole 40 mgJohnson & JohnsonPre-clinical
23
esomeprazole (Nexium®) + Xolaam®AstraZenecaApproved
85
esomeprazoleAstraZenecaPre-clinical
23
EsomeprazoleAstraZenecaApproved
85
EsomeprazoleAstraZenecaApproved
85
esomeprazole magnesiumAstraZenecaPhase 1
33
EsomeprazoleAstraZenecaApproved
85
EsomeprazoleAstraZenecaPhase 3
77
Esomeprazole (Nexium)AstraZenecaApproved
85
OmeprazoleAstraZenecaPhase 3
77
Open Label Run In Esomeprazole + Double Blind Esomeprazole + Double Blind PlaceboAstraZenecaPhase 3
77

Other Products from Ono Pharmaceutical

Sivelestat sodium hydrate + Sivelestat sodium hydrateApproved
85
Abatacept + Placebo matching with Abatacept + MethotrexateApproved
85
Rivastigmine transdermal patchApproved
85
Sitagliptin phosphatePhase 3
77
ONO-4538 + Carboplatin + Paclitaxel + Bevacizumab + PlaceboPhase 3
77